{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T19:47:37Z","timestamp":1782416857665,"version":"3.54.5"},"reference-count":43,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T00:00:00Z","timestamp":1741392000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Natural Science Fund for colleges and universities in Jiangsu Province","award":["21KJB350008"],"award-info":[{"award-number":["21KJB350008"]}]},{"name":"Natural Science Fund for colleges and universities in Jiangsu Province","award":["24KJA350004"],"award-info":[{"award-number":["24KJA350004"]}]},{"name":"Natural Science Fund for colleges and universities in Jiangsu Province","award":["23KJB360016"],"award-info":[{"award-number":["23KJB360016"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antioxidants"],"abstract":"<jats:p>The treatment of ulcerative colitis (UC) has been a major medical challenge due to the lack of safe and effective drugs. Molecular hybridization is a promising strategy for the development of drugs with pleiotropic activity, which has been demonstrated in a wide range of diseases. Tofacitinib has exhibited significant effects on the remission of UC, but a series of adverse effects have occurred during its clinical application. Herein, we propose to utilize a molecular hybridization strategy to link tofacitinib with a cytoprotective H2S donor (ADTOH) to obtain a series of hybridized molecules ZX-4C~ZX-6C. Among them, ZX-4C exhibited the best performance in the H2S release rate and the cytoprotective effects against dextran sulfate sodium (DSS)-induced injury. The in vivo studies showed that ZX-4C could effectively alleviate DSS-induced colitis by enhancing oxidative stress defense and reducing the inflammatory response, demonstrating that it is more potent than the parent drugs. The data from the present study support that this molecular hybridization strategy provides a promising avenue for the treatment of UC.<\/jats:p>","DOI":"10.3390\/antiox14030325","type":"journal-article","created":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T08:46:41Z","timestamp":1741596401000},"page":"325","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Discovery of Novel Tofacitinib\u2013ADTOH Molecular Hybridization Derivatives for the Treatment of Ulcerative Colitis"],"prefix":"10.3390","volume":"14","author":[{"given":"Yi","family":"Mou","sequence":"first","affiliation":[{"name":"College of Pharmacy and Chemistry & Chemical Engineering, Taizhou University, Taizhou 225300, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Wen","sequence":"additional","affiliation":[{"name":"College of Pharmacy and Chemistry & Chemical Engineering, Taizhou University, Taizhou 225300, China"},{"name":"Jiangsu Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing 210009, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[{"name":"College of Pharmacy and Chemistry & Chemical Engineering, Taizhou University, Taizhou 225300, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7173-8024","authenticated-orcid":false,"given":"Yao","family":"Zhao","sequence":"additional","affiliation":[{"name":"College of Pharmacy and Chemistry & Chemical Engineering, Taizhou University, Taizhou 225300, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Ping","family":"Li","sequence":"additional","affiliation":[{"name":"College of Pharmacy and Chemistry & Chemical Engineering, Taizhou University, Taizhou 225300, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Kai","family":"Sha","sequence":"additional","affiliation":[{"name":"College of Pharmacy and Chemistry & Chemical Engineering, Taizhou University, Taizhou 225300, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Juan","family":"Gui","sequence":"additional","affiliation":[{"name":"College of Pharmacy and Chemistry & Chemical Engineering, Taizhou University, Taizhou 225300, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1671-1582","authenticated-orcid":false,"given":"Zheng-Yu","family":"Jiang","sequence":"additional","affiliation":[{"name":"Jiangsu Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing 210009, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-Ming","family":"Xu","sequence":"additional","affiliation":[{"name":"College of Pharmacy and Chemistry & Chemical Engineering, Taizhou University, Taizhou 225300, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,3,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"113114","DOI":"10.1016\/j.ejmech.2020.113114","article-title":"Structure-based discovery of 1H-indole-2-carboxamide derivatives as potent ASK1 inhibitors for potential treatment of ulcerative colitis","volume":"211","author":"Hou","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.ejmech.2007.01.014","article-title":"Antileukotrienic N-arylethyl-2-arylacetamides in the treatment of ulcerative colitis","volume":"42","author":"Junek","year":"2007","journal-title":"Eur. J. Med. Chem."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"114697","DOI":"10.1016\/j.ejmech.2022.114697","article-title":"Design and exploration of gut-restricted bifunctional molecule with TGR5 agonistic and DPP4 inhibitory effects for treating ulcerative colitis","volume":"242","author":"Han","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1021\/acs.jmedchem.1c01813","article-title":"Phosphodiesters as GPR84 Antagonists for the Treatment of Ulcerative Colitis","volume":"65","author":"Chen","year":"2022","journal-title":"J. Med. Chem."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/S0140-6736(16)32126-2","article-title":"Ulcerative colitis","volume":"389","author":"Ungaro","year":"2017","journal-title":"Lancet"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41572-020-0205-x","article-title":"Ulcerative colitis","volume":"6","author":"Kobayashi","year":"2020","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1517\/17425250903206996","article-title":"Balsalazide: A novel 5-aminosalicylate prodrug for the treatment of active ulcerative colitis","volume":"5","author":"Wiggins","year":"2009","journal-title":"Expert. Opin. Drug Metab. Toxicol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"3922","DOI":"10.1016\/j.ejmech.2009.04.018","article-title":"Synthesis, kinetic studies and pharmacological evaluation of mutual azo prodrugs of 5-aminosalicylic acid for colon-specific drug delivery in inflammatory bowel disease","volume":"44","author":"Dhaneshwar","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1080\/14656566.2016.1183648","article-title":"Budesonide for the treatment of ulcerative colitis","volume":"17","author":"Abdalla","year":"2016","journal-title":"Expert. Opin. Pharmacother."},{"key":"ref_10","first-page":"CD000478","article-title":"Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis","volume":"2016","author":"Timmer","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/ajg.2014.357","article-title":"Treatment of IBD: Where we are and where we are going","volume":"110","author":"Bernstein","year":"2015","journal-title":"Am. J. Gastroenterol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1146\/annurev-med-112211-154330","article-title":"The role of anti-inflammatory drugs in colorectal cancer","volume":"64","author":"Wang","year":"2013","journal-title":"Annu. Rev. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1006\/smim.1995.0029","article-title":"The Janus protein tyrosine kinases in hematopoietic cytokine signaling","volume":"7","author":"Ihle","year":"1995","journal-title":"Semin. Immunol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.pharmthera.2018.07.003","article-title":"Targeting JAK-STAT signal transduction in IBD","volume":"192","author":"Soendergaard","year":"2018","journal-title":"Pharmacol. Ther."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1021\/acs.jmedchem.9b01439","article-title":"Discovery of a Gut-Restricted JAK Inhibitor for the Treatment of Inflammatory Bowel Disease","volume":"63","author":"Leonard","year":"2020","journal-title":"J. Med. Chem."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1080\/13543784.2016.1189900","article-title":"Tofacitinib for the treatment of ulcerative colitis","volume":"25","author":"Izzo","year":"2016","journal-title":"Expert. Opin. Investig. Drugs"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1080\/1744666X.2018.1532291","article-title":"Tofacitinib for the treatment of ulcerative colitis","volume":"14","author":"Panes","year":"2018","journal-title":"Expert. Rev. Clin. Immunol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1056\/NEJMoa1112168","article-title":"Tofacitinib, an oral Janus kinase inhibitor, in active ulcerative colitis","volume":"367","author":"Sandborn","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1016\/j.cgh.2020.06.050","article-title":"Safety of Tofacitinib in a Real-World Cohort of Patients With Ulcerative Colitis","volume":"19","author":"Deepak","year":"2021","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1111\/codi.15702","article-title":"Perioperative safety of tofacitinib in surgical ulcerative colitis patients","volume":"23","author":"Lightner","year":"2021","journal-title":"Colorectal Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"s414","DOI":"10.5530\/ijper.55.2s.113","article-title":"Development of Colon Targeting Tablet of a JAK Inhibitor to Combat Chronic Ulcerative Colitis: A Novel Approach for Local Drug Delivery","volume":"55","author":"Vakar","year":"2021","journal-title":"Indian J. Pharm. Educ. Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s11095-019-2587-6","article-title":"A Macromolecular Janus Kinase (JAK) Inhibitor Prodrug Effectively Ameliorates Dextran Sulfate Sodium-Induced Ulcerative Colitis in Mice","volume":"36","author":"Zhao","year":"2019","journal-title":"Pharm. Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"4926","DOI":"10.1021\/acs.jmedchem.1c02166","article-title":"Discovery of a Colon-Targeted Azo Prodrug of Tofacitinib through the Establishment of Colon-Specific Delivery Systems Constructed by 5-ASA-PABA-MAC and 5-ASA-PABA-Diamine for the Treatment of Ulcerative Colitis","volume":"65","author":"Zhao","year":"2022","journal-title":"J. Med. Chem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1053\/j.gastro.2009.04.012","article-title":"Endogenous and exogenous hydrogen sulfide promotes resolution of colitis in rats","volume":"137","author":"Wallace","year":"2009","journal-title":"Gastroenterology"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1089\/ars.2011.4351","article-title":"Hydrogen sulfide: An endogenous mediator of resolution of inflammation and injury","volume":"17","author":"Wallace","year":"2012","journal-title":"Antioxid. Redox Signal"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1007\/s10620-010-1461-5","article-title":"Endogenous hydrogen sulfide is an anti-inflammatory molecule in dextran sodium sulfate-induced colitis in mice","volume":"56","author":"Hirata","year":"2011","journal-title":"Dig. Dis. Sci."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1089\/ars.2009.2900","article-title":"Physiological and pathophysiological roles of hydrogen sulfide in the gastrointestinal tract","volume":"12","author":"Wallace","year":"2010","journal-title":"Antioxid. Redox Signal"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1161\/CIRCULATIONAHA.107.753467","article-title":"Characterization of a novel, water-soluble hydrogen sulfide-releasing molecule (GYY4137): New insights into the biology of hydrogen sulfide","volume":"117","author":"Li","year":"2008","journal-title":"Circulation"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.freeradbiomed.2006.12.011","article-title":"Anti-inflammatory and gastrointestinal effects of a novel diclofenac derivative","volume":"42","author":"Li","year":"2007","journal-title":"Free Radic. Biol. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1021\/acs.jmedchem.5b01223","article-title":"Synthesis and Pharmacological Evaluation of Novel Adenine-Hydrogen Sulfide Slow Release Hybrids Designed as Multitarget Cardioprotective Agents","volume":"59","author":"Lougiakis","year":"2016","journal-title":"J. Med. Chem."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Wen, S., Cao, C., Ge, J., Yang, W., Wang, Y., and Mou, Y. (2022). Research Progress of H(2)S Donors Conjugate Drugs Based on ADTOH. Molecules, 28.","DOI":"10.3390\/molecules28010331"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1053\/j.gastro.2006.11.042","article-title":"Gastrointestinal safety and anti-inflammatory effects of a hydrogen sulfide-releasing diclofenac derivative in the rat","volume":"132","author":"Wallace","year":"2007","journal-title":"Gastroenterology"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/j.1476-5381.2009.00611.x","article-title":"Markedly reduced toxicity of a hydrogen sulphide-releasing derivative of naproxen (ATB-346)","volume":"159","author":"Wallace","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.phrs.2017.12.022","article-title":"Anti-inflammatory effect of ATB-352, a H2S -releasing ketoprofen derivative, on lipopolysaccharide-induced periodontitis in rats","volume":"132","author":"Gugliandolo","year":"2018","journal-title":"Pharmacol. Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.cgh.2020.02.017","article-title":"Combination Biologic Therapy in Inflammatory Bowel Disease: Experience From a Tertiary Care Center","volume":"19","author":"Kwapisz","year":"2021","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"7874","DOI":"10.1021\/jm5006463","article-title":"Polypharmacology: Challenges and opportunities in drug discovery","volume":"57","author":"Anighoro","year":"2014","journal-title":"J. Med. Chem."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1021\/acs.jmedchem.8b00760","article-title":"Polypharmacology by Design: A Medicinal Chemist\u2019s Perspective on Multitargeting Compounds","volume":"62","author":"Proschak","year":"2019","journal-title":"J. Med. Chem."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1039\/C0PY00324G","article-title":"Self-immolative linkers in polymeric delivery systems","volume":"2","author":"Blencowe","year":"2011","journal-title":"Polym. Chem."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.addr.2017.06.013","article-title":"Prodrugs in medicinal chemistry and enzyme prodrug therapies","volume":"118","author":"Walther","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/cmdc.201402393","article-title":"Discovery of MK-8970: An acetal carbonate prodrug of raltegravir with enhanced colonic absorption","volume":"10","author":"Walji","year":"2015","journal-title":"ChemMedChem"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1021\/mp400226p","article-title":"Acetal derivatives as prodrugs of resveratrol","volume":"10","author":"Mattarei","year":"2013","journal-title":"Mol. Pharm."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"21417","DOI":"10.1021\/acsnano.2c09788","article-title":"Two-Stage SN38 Release from a Core-Shell Nanoparticle Enhances Tumor Deposition and Antitumor Efficacy for Synergistic Combination with Immune Checkpoint Blockade","volume":"16","author":"Jiang","year":"2022","journal-title":"ACS Nano"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/s41591-022-01680-y","article-title":"Ulcerative colitis is characterized by a plasmablast-skewed humoral response associated with disease activity","volume":"28","author":"Uzzan","year":"2022","journal-title":"Nat. Med."}],"container-title":["Antioxidants"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-3921\/14\/3\/325\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:49:31Z","timestamp":1760028571000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-3921\/14\/3\/325"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,8]]},"references-count":43,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["antiox14030325"],"URL":"https:\/\/doi.org\/10.3390\/antiox14030325","relation":{},"ISSN":["2076-3921"],"issn-type":[{"value":"2076-3921","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,8]]}}}